Categories AlphaGraphs, Cannabis, Earnings
ACB Earnings Infographic: Aurora Cannabis Q2 2023 revenue rises
Aurora Cannabis, Inc. (NASDAQ: ACB) on Friday reported a narrower net loss for the second quarter of 2023. The company’s revenues moved up 2% year-over-year during the quarter.
The Canada-based medical marijuana company reported a net loss from continuing operations of C$67.2 million for the second quarter, compared to a loss of C$75.1 million in the year-ago period. Adjusted EBITDA was C$1.4 million during the three-month period, compared to a loss of C$7.1 million in the prior-year quarter. Total revenues increased 2% annually to C$61.7 million.
Read management/analysts’ comments on quarterly reports
“We have right-sized our business while remaining the #1 Canadian LP in global medical cannabis revenues, and having demonstrated organic quarter-over-quarter revenue growth across all of our cannabis segments during Q2 2023,” said Miguel Martin, chief executive officer of Aurora Cannabis.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%
